Literature DB >> 3499152

Deletion of C4A genes in patients with systemic lupus erythematosus.

M E Kemp1, J P Atkinson, V M Skanes, R P Levine, D D Chaplin.   

Abstract

To define the relationship between inheritance of major histocompatibility complex (MHC) alleles and susceptibility to the development of systemic lupus erythematosus (SLE), we examined the MHC class I, II, and III phenotypes of white SLE patients and characterized the structures of their class III MHC genes, using Southern blotting. Nine of 88 SLE patients (10.2%) were C4A null. As detected by Southern blot analysis, the C4A gene was deleted from both chromosomes in 8 of the 9 C4A-null patients. Deletions affecting only 1 chromosome (heterozygous) were detected in the remaining C4A-null patient and in 34.5% of SLE patients who were not C4A deficient (compared with 12.5% of controls; P less than 0.05). These results indicate that deletion of the C4A gene is a common genetic marker for SLE. Deletions of C4A were observed most commonly as part of the HLA-B8;DR3 extended haplotype, although deletions were also detected in different HLA haplotypes. Because of the critical role of C4A in the processing of immune complexes, deficiency of C4A may, itself, confer susceptibility to the development of SLE.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499152     DOI: 10.1002/art.1780300908

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  24 in total

1.  Analysis of human C4A and C4B binding to an immune complex in serum.

Authors:  B D Reilly
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

Review 2.  Complement deficiency.

Authors:  K M O'Neil
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

Review 3.  Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology.

Authors:  J B Harley; R H Scofield
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

4.  Counterregulatory effects of interferon-gamma and endotoxin on expression of the human C4 genes.

Authors:  J Kulics; H R Colten; D H Perlmutter
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

5.  Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome.

Authors:  R A Asherson; H M Fei; H L Staub; M A Khamashta; G R Hughes; R I Fox
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

6.  Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE).

Authors:  M A Dragon-Durey; N Rougier; J P Clauvel; S Caillat-Zucman; P Remy; L Guillevin; F Liote; J Blouin; F Ariey; B U Lambert; M D Kazatchkine; L Weiss
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

7.  Population and family studies of three disease-related polymorphic genes in systemic lupus erythematosus.

Authors:  D F Huang; K A Siminovitch; X Y Liu; T Olee; N J Olsen; C Berry; D A Carson; P P Chen
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility.

Authors:  D De Juan; J M Martín-Villa; J J Gómez-Reino; J L Vicario; A Corell; J Martínez-Laso; D Benmammar; A Arnaiz-Villena
Journal:  Hum Genet       Date:  1993-07       Impact factor: 4.132

Review 9.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

10.  Interleukin 2 production in a family with systemic lupus erythematosus and a C4Q0 heterozygous inheritance.

Authors:  C Gutierrez; E Cabrero; J L Vicario; M Martín Villa; M A Rengel; F J Gomez Campdera; M Yebra; E Fernández-Cruz; A Arnaiz Villena
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.